Clinical Risk Grouping Solutions Market by Product (Scorecard & Visualization Tools, Dashboard Analytics, Risk Reporting), Deployment (Private Cloud, Public Cloud, Hybrid Cloud), End-User and Region - Global Forecast to 2024
Increasing focus on risk management solutions is expected to drive the growth of the clinical risk grouping solutions market
The clinical risk grouping solutions market is projected to reach USD 829 million by 2024 from USD 427 million in 2019, at a CAGR of 14.2%. Focus on risk management and big data solutions are driving the market for clinical risk grouping solutions. However, a lack of infrastructure for supporting this technology is expected to restrain the growth of the market to a certain extent during the forecast period.
Dashboard analytics segment to show the fastest growth during the forecast period
Based on product, the clinical risk grouping solutions market is segmented into three major categories, viz., scorecard & visualization tools, dashboard analytics, and risk reporting. The dashboard analytics segment is expected to witness one of the highest CAGR within the clinical risk grouping solutions market. High adoption of dashboard analytics by healthcare providers, the increasing adoption of risk management solutions in the healthcare industry, growing requirements for accuracy & quality of patient care, and the rising use of big data solutions in healthcare are driving the growth of the segment.
Private cloud to hold the largest share of the clinical risk grouping solutions market during the forecast period
Based on the deployment model, the clinical risk grouping solutions market is segmented into private cloud, public cloud, and hybrid cloud. In 2018, the private cloud segment accounted for the dominant share of the clinical risk grouping solutions market. The large share of this segment is attributed to the fact that private cloud deployment offers the best security for sensitive data. Additionally, a private cloud offers on-demand infrastructure with dedicated resources that can be shared across domains, applications, and units within the same organization.
North America accounted for the largest share of the market in 2018, whereas the Asia Pacific is expected to be the fastest-growing market
The study discusses the clinical risk grouping solutions market trends for North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the global clinical risk grouping solutions market. The large share of North America can be attributed to the support for adopting HCIT by providers and payers, increasing focus on population health services, and greater availability of clinical risk grouping solutions
However, Asia Pacific is expected to be the fastest-growing market with the highest CAGR during the forecast period. Factors such as the presence of a larger patient population demanding better healthcare at lower costs, economic growth, rising geriatric population, emergence of big data in healthcare, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the clinical risk grouping solutions market in the Asia Pacific.
The breakup of primary participants is as mentioned below:
Research Coverage:
The report analyzes the clinical risk grouping solutions market and aims at estimating the market size and future growth potential of this market based on various segments such as product, deployment model, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
The clinical risk grouping solutions market is projected to reach USD 829 million by 2024 from USD 427 million in 2019, at a CAGR of 14.2%. Focus on risk management and big data solutions are driving the market for clinical risk grouping solutions. However, a lack of infrastructure for supporting this technology is expected to restrain the growth of the market to a certain extent during the forecast period.
Dashboard analytics segment to show the fastest growth during the forecast period
Based on product, the clinical risk grouping solutions market is segmented into three major categories, viz., scorecard & visualization tools, dashboard analytics, and risk reporting. The dashboard analytics segment is expected to witness one of the highest CAGR within the clinical risk grouping solutions market. High adoption of dashboard analytics by healthcare providers, the increasing adoption of risk management solutions in the healthcare industry, growing requirements for accuracy & quality of patient care, and the rising use of big data solutions in healthcare are driving the growth of the segment.
Private cloud to hold the largest share of the clinical risk grouping solutions market during the forecast period
Based on the deployment model, the clinical risk grouping solutions market is segmented into private cloud, public cloud, and hybrid cloud. In 2018, the private cloud segment accounted for the dominant share of the clinical risk grouping solutions market. The large share of this segment is attributed to the fact that private cloud deployment offers the best security for sensitive data. Additionally, a private cloud offers on-demand infrastructure with dedicated resources that can be shared across domains, applications, and units within the same organization.
North America accounted for the largest share of the market in 2018, whereas the Asia Pacific is expected to be the fastest-growing market
The study discusses the clinical risk grouping solutions market trends for North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the global clinical risk grouping solutions market. The large share of North America can be attributed to the support for adopting HCIT by providers and payers, increasing focus on population health services, and greater availability of clinical risk grouping solutions
However, Asia Pacific is expected to be the fastest-growing market with the highest CAGR during the forecast period. Factors such as the presence of a larger patient population demanding better healthcare at lower costs, economic growth, rising geriatric population, emergence of big data in healthcare, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the clinical risk grouping solutions market in the Asia Pacific.
The breakup of primary participants is as mentioned below:
- By Company Type: Tier 1 (50%), Tier 2 (10%), and Tier 3 (40%)
- By Designation: C-level (10%), Director-level (30%), and Others (60%)
- By Region: North America (40%), Europe (30%), Asia Pacific (10%), Latin America (10%), and the Middle East and Africa (10%)
Research Coverage:
The report analyzes the clinical risk grouping solutions market and aims at estimating the market size and future growth potential of this market based on various segments such as product, deployment model, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the global clinical risk grouping solutions market. The report analyzes this market by product, deployment model, end-user, and region
- Product Enhancement/Innovation: Detailed insights on the upcoming trends and product launches in the global clinical risk grouping solutions market
- Market Development: Comprehensive information on the lucrative emerging markets by product, deployment model, end-user, and region
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global clinical risk grouping solutions market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global clinical risk grouping solutions market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 DATA TRIANGULATION APPROACH
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CLINICAL RISK GROUPING SOLUTIONS: MARKET OVERVIEW
4.2 CLINICAL RISK GROUPING SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.3 REGIONAL MIX: CLINICAL RISK GROUPING SOLUTIONS MARKET (2019–2024)
4.4 CLINICAL RISK GROUPING SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Advantages of risk management solutions
5.2.1.2 Rising usage of big data solutions
5.2.2 RESTRAINTS
5.2.2.1 Lack of infrastructure
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing physician burnout due to documentation needs
5.2.3.2 Increasing focus on AI and machine learning
5.2.4 CHALLENGES
5.2.4.1 Scarcity of skilled healthcare IT professionals
5.2.4.2 Patient data privacy concerns
5.2.5 BURNING ISSUES
5.2.5.1 Implementation of solutions reduces administrative expenses but increases the burden on patients
6 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 SCORECARDS & VISUALIZATION TOOLS
6.2.1 NEED TO INCREASE PATIENT ACCURACY AND FORECAST RISKS ARE DRIVING THE DEMAND FOR SCORECARDS & VISUALIZATION TOOLS
6.3 DASHBOARD ANALYTICS SOLUTIONS
6.3.1 DASHBOARD ANALYTICS SOLUTIONS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
6.4 RISK REPORTING SOLUTIONS
6.4.1 INCREASING ADOPTION OF RISK REPORTING SOLUTIONS BY HEALTHCARE PROVIDERS TO FUEL MARKET GROWTH
7 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE
7.1 INTRODUCTION
7.2 PRIVATE CLOUD
7.2.1 HIGH DATA SECURITY OF PRIVATE CLOUD MODELS IS DRIVING MARKET GROWTH
7.3 PUBLIC CLOUD
7.3.1 PRICE-EFFECTIVENESS OF PUBLIC OVER PRIVATE CLOUDS HAS DRIVEN END-USER PREFERENCE
7.4 HYBRID CLOUD
7.4.1 HYBRID CLOUD ARCHITECTURE PROVIDES FLEXIBILITY AND THE ABILITY TO AVOID VENDOR LOCK-IN
8 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.2.1 HOSPITALS ARE THE LARGEST END USERS OF THE CLINICAL RISK GROUPING SOLUTIONS MARKET
8.3 PAYERS
8.3.1 PAYERS CAN IDENTIFY PATTERNS IN CLAIMS AND INTERVENE IN FRAUDULENT CLAIMS—A MAJOR FACTOR SUPPORTING THE ADOPTION OF CLINICAL RISK GROUPING SOLUTIONS
8.4 AMBULATORY CARE CENTERS
8.4.1 IMPLEMENTATION OF MANDATES TO COMPLY WITH QUALITY MEASURES TO SUPPORT THE ADOPTION OF CLINICAL RISK GROUPING SOLUTIONS IN AMBULATORY CARE CENTERS
8.5 LONG-TERM CARE CENTERS
8.5.1 GROWING NUMBER OF LONG-TERM CARE CENTERS TO DRIVE MARKET GROWTH
8.6 OTHER END USERS
9 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 The US dominates the North American clinical risk grouping solutions market
9.2.2 CANADA
9.2.2.1 Increasing government focus on population health management initiatives will propel market growth in Canada
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Infrastructural development and focus on risk management have driven market growth in Germany
9.3.2 UK
9.3.2.1 Favorable regulatory outlook has pushed the adoption of HCIT solutions in the UK
9.3.3 FRANCE
9.3.3.1 Initiatives taken by the French government to promote the use of healthcare IT solutions will drive market growth
9.3.4 REST OF EUROPE (ROE)
9.4 ASIA PACIFIC
9.4.1 ASIA IS EXPECTED TO WITNESS HIGH GROWTH IN POPULATION AND DEMAND FOR HEALTHCARE SERVICES
9.5 LATIN AMERICA
9.5.1 COUNTRIES SUCH AS BRAZIL AND MEXICO ARE EXPLORING NEW METHODS TO MANAGE CLINICAL INFORMATION
9.6 MIDDLE EAST & AFRICA
9.6.1 MIDDLE EASTERN COUNTRIES ARE INVESTING SIGNIFICANTLY IN HCIT INFRASTRUCTURAL DEVELOPMENT
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 COMPETITIVE LEADERSHIP MAPPING
10.2.1 VISIONARY LEADERS
10.2.2 INNOVATORS
10.2.3 DYNAMIC DIFFERENTIATORS
10.2.4 EMERGING COMPANIES
10.3 COMPANY ANALYSIS, BY PRODUCT AND END USER
10.4 COMPETITIVE SITUATIONS AND TRENDS
11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 3M COMPANY
11.2 OPTUM INC. (A SUBSIDIARY OF UNITEDHEALTH GROUP INC.)
11.3 CERNER CORPORATION
11.4 NUANCE COMMUNICATIONS
11.5 CONDUENT INCORPORATED
11.6 HBI SOLUTIONS, INC.
11.7 4S INFORMATION SYSTEMS LTD.
11.8 JOHNS HOPKINS UNIVERSITY
11.9 LIGHTBEAM HEALTH SOLUTIONS, LLC
11.10 DYNAMIC HEALTHCARE SYSTEMS, INC.
11.11 PERAHEALTH, INC.
11.12 HEALTH CATALYST INC.
11.13 EVOLENT HEALTH
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 MARKET SIZING & VALIDATION APPROACH
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 DATA TRIANGULATION APPROACH
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CLINICAL RISK GROUPING SOLUTIONS: MARKET OVERVIEW
4.2 CLINICAL RISK GROUPING SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.3 REGIONAL MIX: CLINICAL RISK GROUPING SOLUTIONS MARKET (2019–2024)
4.4 CLINICAL RISK GROUPING SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Advantages of risk management solutions
5.2.1.2 Rising usage of big data solutions
5.2.2 RESTRAINTS
5.2.2.1 Lack of infrastructure
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing physician burnout due to documentation needs
5.2.3.2 Increasing focus on AI and machine learning
5.2.4 CHALLENGES
5.2.4.1 Scarcity of skilled healthcare IT professionals
5.2.4.2 Patient data privacy concerns
5.2.5 BURNING ISSUES
5.2.5.1 Implementation of solutions reduces administrative expenses but increases the burden on patients
6 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 SCORECARDS & VISUALIZATION TOOLS
6.2.1 NEED TO INCREASE PATIENT ACCURACY AND FORECAST RISKS ARE DRIVING THE DEMAND FOR SCORECARDS & VISUALIZATION TOOLS
6.3 DASHBOARD ANALYTICS SOLUTIONS
6.3.1 DASHBOARD ANALYTICS SOLUTIONS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
6.4 RISK REPORTING SOLUTIONS
6.4.1 INCREASING ADOPTION OF RISK REPORTING SOLUTIONS BY HEALTHCARE PROVIDERS TO FUEL MARKET GROWTH
7 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE
7.1 INTRODUCTION
7.2 PRIVATE CLOUD
7.2.1 HIGH DATA SECURITY OF PRIVATE CLOUD MODELS IS DRIVING MARKET GROWTH
7.3 PUBLIC CLOUD
7.3.1 PRICE-EFFECTIVENESS OF PUBLIC OVER PRIVATE CLOUDS HAS DRIVEN END-USER PREFERENCE
7.4 HYBRID CLOUD
7.4.1 HYBRID CLOUD ARCHITECTURE PROVIDES FLEXIBILITY AND THE ABILITY TO AVOID VENDOR LOCK-IN
8 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.2.1 HOSPITALS ARE THE LARGEST END USERS OF THE CLINICAL RISK GROUPING SOLUTIONS MARKET
8.3 PAYERS
8.3.1 PAYERS CAN IDENTIFY PATTERNS IN CLAIMS AND INTERVENE IN FRAUDULENT CLAIMS—A MAJOR FACTOR SUPPORTING THE ADOPTION OF CLINICAL RISK GROUPING SOLUTIONS
8.4 AMBULATORY CARE CENTERS
8.4.1 IMPLEMENTATION OF MANDATES TO COMPLY WITH QUALITY MEASURES TO SUPPORT THE ADOPTION OF CLINICAL RISK GROUPING SOLUTIONS IN AMBULATORY CARE CENTERS
8.5 LONG-TERM CARE CENTERS
8.5.1 GROWING NUMBER OF LONG-TERM CARE CENTERS TO DRIVE MARKET GROWTH
8.6 OTHER END USERS
9 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 The US dominates the North American clinical risk grouping solutions market
9.2.2 CANADA
9.2.2.1 Increasing government focus on population health management initiatives will propel market growth in Canada
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Infrastructural development and focus on risk management have driven market growth in Germany
9.3.2 UK
9.3.2.1 Favorable regulatory outlook has pushed the adoption of HCIT solutions in the UK
9.3.3 FRANCE
9.3.3.1 Initiatives taken by the French government to promote the use of healthcare IT solutions will drive market growth
9.3.4 REST OF EUROPE (ROE)
9.4 ASIA PACIFIC
9.4.1 ASIA IS EXPECTED TO WITNESS HIGH GROWTH IN POPULATION AND DEMAND FOR HEALTHCARE SERVICES
9.5 LATIN AMERICA
9.5.1 COUNTRIES SUCH AS BRAZIL AND MEXICO ARE EXPLORING NEW METHODS TO MANAGE CLINICAL INFORMATION
9.6 MIDDLE EAST & AFRICA
9.6.1 MIDDLE EASTERN COUNTRIES ARE INVESTING SIGNIFICANTLY IN HCIT INFRASTRUCTURAL DEVELOPMENT
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 COMPETITIVE LEADERSHIP MAPPING
10.2.1 VISIONARY LEADERS
10.2.2 INNOVATORS
10.2.3 DYNAMIC DIFFERENTIATORS
10.2.4 EMERGING COMPANIES
10.3 COMPANY ANALYSIS, BY PRODUCT AND END USER
10.4 COMPETITIVE SITUATIONS AND TRENDS
11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 3M COMPANY
11.2 OPTUM INC. (A SUBSIDIARY OF UNITEDHEALTH GROUP INC.)
11.3 CERNER CORPORATION
11.4 NUANCE COMMUNICATIONS
11.5 CONDUENT INCORPORATED
11.6 HBI SOLUTIONS, INC.
11.7 4S INFORMATION SYSTEMS LTD.
11.8 JOHNS HOPKINS UNIVERSITY
11.9 LIGHTBEAM HEALTH SOLUTIONS, LLC
11.10 DYNAMIC HEALTHCARE SYSTEMS, INC.
11.11 PERAHEALTH, INC.
11.12 HEALTH CATALYST INC.
11.13 EVOLENT HEALTH
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 MARKET SIZING & VALIDATION APPROACH
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 2 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 3 SCORECARDS & VISUALIZATION TOOLS: KEY BRANDS
TABLE 4 SCORECARDS & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 5 DASHBOARD ANALYTICS SOLUTIONS: KEY BRANDS
TABLE 6 DASHBOARD ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 7 RISK REPORTING SOLUTIONS: KEY BRANDS
TABLE 8 RISK REPORTING SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 9 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 10 PRIVATE CLOUD-DEPLOYED CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 11 PUBLIC CLOUD-DEPLOYED CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12 HYBRID CLOUD-DEPLOYED CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 14 CLINICAL RISK GROUPING SOLUTIONS FOR HOSPITALS
TABLE 15 CLINICAL RISK GROUPING SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16 CLINICAL RISK GROUPING SOLUTIONS FOR PAYERS
TABLE 17 CLINICAL RISK GROUPING SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18 CLINICAL RISK GROUPING SOLUTIONS FOR AMBULATORY CARE CENTERS
TABLE 19 CLINICAL RISK GROUPING SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20 CLINICAL RISK GROUPING SOLUTIONS FOR LONG-TERM CARE CENTERS
TABLE 21 CLINICAL RISK GROUPING SOLUTIONS MARKET FOR LONG-TERM CARE CENTERS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 22 CLINICAL RISK GROUPING SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 23 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 24 NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 25 NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 27 NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 28 US: KEY MACROINDICATORS
TABLE 29 US: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 30 US: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 31 US: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 32 CANADA: KEY MACROINDICATORS
TABLE 33 CANADA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 34 CANADA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 35 CANADA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 36 EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 37 EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 38 EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 39 EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 40 GERMANY: KEY MACROINDICATORS
TABLE 41 GERMANY: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 42 GERMANY: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 43 GERMANY: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 44 UK: KEY MACROINDICATORS
TABLE 45 UK: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 46 UK: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 47 UK: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 48 FRANCE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 49 FRANCE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 50 FRANCE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 51 ROE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 52 ROE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 53 ROE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 54 ASIA PACIFIC: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 55 ASIA PACIFIC: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 56 ASIA PACIFIC: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 57 LATIN AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 58 LATIN AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 59 LATIN AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 60 MIDDLE EAST AND AFRICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 61 MIDDLE EAST AND AFRICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 62 MIDDLE EAST AND AFRICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 63 PRODUCT LAUNCHES AND ENHANCEMENTS (2017–2019)
TABLE 64 ACQUISITIONS, JOINT VENTURES, AND MERGERS (2017–2019)
TABLE 65 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS (2018–2019)
TABLE 66 EXPANSIONS (2017)
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 2 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 3 SCORECARDS & VISUALIZATION TOOLS: KEY BRANDS
TABLE 4 SCORECARDS & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 5 DASHBOARD ANALYTICS SOLUTIONS: KEY BRANDS
TABLE 6 DASHBOARD ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 7 RISK REPORTING SOLUTIONS: KEY BRANDS
TABLE 8 RISK REPORTING SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 9 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 10 PRIVATE CLOUD-DEPLOYED CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 11 PUBLIC CLOUD-DEPLOYED CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12 HYBRID CLOUD-DEPLOYED CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 14 CLINICAL RISK GROUPING SOLUTIONS FOR HOSPITALS
TABLE 15 CLINICAL RISK GROUPING SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16 CLINICAL RISK GROUPING SOLUTIONS FOR PAYERS
TABLE 17 CLINICAL RISK GROUPING SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18 CLINICAL RISK GROUPING SOLUTIONS FOR AMBULATORY CARE CENTERS
TABLE 19 CLINICAL RISK GROUPING SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20 CLINICAL RISK GROUPING SOLUTIONS FOR LONG-TERM CARE CENTERS
TABLE 21 CLINICAL RISK GROUPING SOLUTIONS MARKET FOR LONG-TERM CARE CENTERS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 22 CLINICAL RISK GROUPING SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 23 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 24 NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 25 NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 27 NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 28 US: KEY MACROINDICATORS
TABLE 29 US: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 30 US: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 31 US: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 32 CANADA: KEY MACROINDICATORS
TABLE 33 CANADA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 34 CANADA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 35 CANADA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 36 EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 37 EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 38 EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 39 EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 40 GERMANY: KEY MACROINDICATORS
TABLE 41 GERMANY: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 42 GERMANY: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 43 GERMANY: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 44 UK: KEY MACROINDICATORS
TABLE 45 UK: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 46 UK: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 47 UK: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 48 FRANCE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 49 FRANCE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 50 FRANCE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 51 ROE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 52 ROE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 53 ROE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 54 ASIA PACIFIC: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 55 ASIA PACIFIC: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 56 ASIA PACIFIC: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 57 LATIN AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 58 LATIN AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 59 LATIN AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 60 MIDDLE EAST AND AFRICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 61 MIDDLE EAST AND AFRICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017–2024 (USD MILLION)
TABLE 62 MIDDLE EAST AND AFRICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 63 PRODUCT LAUNCHES AND ENHANCEMENTS (2017–2019)
TABLE 64 ACQUISITIONS, JOINT VENTURES, AND MERGERS (2017–2019)
TABLE 65 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS (2018–2019)
TABLE 66 EXPANSIONS (2017)
LIST OF FIGURES
FIGURE 1 CLINICAL RISK GROUPING SOLUTIONS MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BOTTOM-UP APPROACH
FIGURE 5 TOP-DOWN APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION)
FIGURE 8 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2019 VS. 2024 (USD MILLION)
FIGURE 9 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE CLINICAL RISK GROUPING SOLUTIONS MARKET
FIGURE 11 ADVANTAGES OF RISK MANAGEMENT SOLUTIONS TO DRIVE MARKET GROWTH
FIGURE 12 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 13 NORTH AMERICA WILL CONTINUE TO DOMINATE THE CLINICAL RISK GROUPING SOLUTIONS MARKET IN 2024
FIGURE 14 ASIA PACIFIC TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD
FIGURE 15 CLINICAL RISK GROUPING SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 HEALTHCARE DATA BREACHES IN THE US (2016–2019)
FIGURE 17 SCORECARDS & VISUALIZATION TOOLS SEGMENT TO DOMINATE THE CLINICAL RISK GROUPING SOLUTIONS MARKET IN 2019
FIGURE 18 PRIVATE CLOUD TO HOLD THE LARGEST SHARE OF THE CLINICAL RISK GROUPING SOLUTIONS MARKET DURING THE FORECAST PERIOD
FIGURE 19 HOSPITALS TO DOMINATE THE CLINICAL RISK GROUPING SOLUTIONS MARKET DURING THE FORECAST PERIOD
FIGURE 20 CLINICAL RISK GROUPING SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 21 NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET SNAPSHOT
FIGURE 22 EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET SNAPSHOT
FIGURE 23 KEY DEVELOPMENTS IN THE CLINICAL RISK GROUPING SOLUTIONS MARKET BETWEEN 2016 AND 2019
FIGURE 24 CLINICAL RISK GROUPING SOLUTIONS MARKET COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 25 3M AND OPTUM ARE THE LEADING PLAYERS IN THE CLINICAL RISK GROUPING SOLUTIONS MARKET
FIGURE 26 3M COMPANY: COMPANY SNAPSHOT (2018)
FIGURE 27 OPTUM INC.: COMPANY SNAPSHOT (2018)
FIGURE 28 CERNER: COMPANY SNAPSHOT (2018)
FIGURE 29 NUANCE COMMUNICATIONS: COMPANY SNAPSHOT (2018)
FIGURE 30 CONDUENT INCORPORATED: COMPANY SNAPSHOT (2018)
FIGURE 31 EVOLENT HEALTH: COMPANY SNAPSHOT (2018)
FIGURE 1 CLINICAL RISK GROUPING SOLUTIONS MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BOTTOM-UP APPROACH
FIGURE 5 TOP-DOWN APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION)
FIGURE 8 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2019 VS. 2024 (USD MILLION)
FIGURE 9 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE CLINICAL RISK GROUPING SOLUTIONS MARKET
FIGURE 11 ADVANTAGES OF RISK MANAGEMENT SOLUTIONS TO DRIVE MARKET GROWTH
FIGURE 12 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 13 NORTH AMERICA WILL CONTINUE TO DOMINATE THE CLINICAL RISK GROUPING SOLUTIONS MARKET IN 2024
FIGURE 14 ASIA PACIFIC TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD
FIGURE 15 CLINICAL RISK GROUPING SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 HEALTHCARE DATA BREACHES IN THE US (2016–2019)
FIGURE 17 SCORECARDS & VISUALIZATION TOOLS SEGMENT TO DOMINATE THE CLINICAL RISK GROUPING SOLUTIONS MARKET IN 2019
FIGURE 18 PRIVATE CLOUD TO HOLD THE LARGEST SHARE OF THE CLINICAL RISK GROUPING SOLUTIONS MARKET DURING THE FORECAST PERIOD
FIGURE 19 HOSPITALS TO DOMINATE THE CLINICAL RISK GROUPING SOLUTIONS MARKET DURING THE FORECAST PERIOD
FIGURE 20 CLINICAL RISK GROUPING SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 21 NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET SNAPSHOT
FIGURE 22 EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET SNAPSHOT
FIGURE 23 KEY DEVELOPMENTS IN THE CLINICAL RISK GROUPING SOLUTIONS MARKET BETWEEN 2016 AND 2019
FIGURE 24 CLINICAL RISK GROUPING SOLUTIONS MARKET COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 25 3M AND OPTUM ARE THE LEADING PLAYERS IN THE CLINICAL RISK GROUPING SOLUTIONS MARKET
FIGURE 26 3M COMPANY: COMPANY SNAPSHOT (2018)
FIGURE 27 OPTUM INC.: COMPANY SNAPSHOT (2018)
FIGURE 28 CERNER: COMPANY SNAPSHOT (2018)
FIGURE 29 NUANCE COMMUNICATIONS: COMPANY SNAPSHOT (2018)
FIGURE 30 CONDUENT INCORPORATED: COMPANY SNAPSHOT (2018)
FIGURE 31 EVOLENT HEALTH: COMPANY SNAPSHOT (2018)
